UNLIMITED TURBO LONG - ABBOTT LABORATORIES Stock

Certificat

DE000PF9N5F5

Delayed Deutsche Boerse AG 08:21:07 2024-06-26 EDT
1.58 EUR +1.28% Intraday chart for UNLIMITED TURBO LONG - ABBOTT LABORATORIES
Current month+23.81%
1 month+5.41%
Date Price Change
24-06-26 1.58 +1.28%
24-06-25 1.56 0.00%
24-06-24 1.56 -3.11%
24-06-21 1.61 -4.73%
24-06-20 1.69 +19.01%

Delayed Quote Deutsche Boerse AG

Last update June 26, 2024 at 08:21 am

More quotes

Static data

Product typeKnock-Out ohne Stop Loss
Buy / SellCALL
Underlying ABBOTT LABORATORIES
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PF9N5F
ISINDE000PF9N5F5
Date issued 2021-05-04
Strike 89.08 $
Maturity Unlimited
Parity 10 : 1
Emission price 4.02
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 6.02
Lowest since issue 0.66
Spread 0.03
Spread %1.88%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
105.5 USD
Average target price
125.2 USD
Spread / Average Target
+18.64%
Consensus